foropafant has been researched along with Asthma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, PJ; Cluzel, M; Evans, DJ; O'Connor, BJ | 1 |
| Barberà, JA; Chung, KF; Gómez, FP; Peinado, VI; Roca, J; Rodriguez-Roisin, R | 1 |
| Barberà, JA; Chung, KF; Gómez, FP; Iglesia, R; Marrades, RM; Roca, J; Rodriguez-Roisin, RM | 1 |
3 trial(s) available for foropafant and Asthma
| Article | Year |
|---|---|
Effects of a potent platelet-activating factor antagonist, SR27417A, on allergen-induced asthmatic responses.
Topics: Adult; Allergens; Asthma; Cross-Over Studies; Double-Blind Method; Forced Expiratory Volume; Humans; Male; Platelet Activating Factor; Thiazoles | 1997 |
Effect of a platelet-activating factor (PAF) antagonist, SR 27417A, on PAF-induced gas exchange abnormalities in mild asthma.
Topics: Adult; Airway Resistance; Asthma; Blood Gas Analysis; Female; Humans; Leukocyte Count; Male; Neutrophils; Platelet Activating Factor; Pulmonary Gas Exchange; Thiazoles | 1998 |
Gas exchange response to a PAF receptor antagonist, SR 27417A, in acute asthma: a pilot study.
Topics: Acute Disease; Adult; Airway Resistance; Asthma; Blood Flow Velocity; Blood Gas Analysis; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Male; Pilot Projects; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Pulmonary Circulation; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Thiazoles; Ventilation-Perfusion Ratio | 1999 |